BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 3:51:00 PM | Browse: 1156 | Download: 866
Publication Name World Journal of Gastroenterology
Manuscript ID 7441
Country United States
Received
2013-11-19 14:04
Peer-Review Started
2013-11-19 16:57
To Make the First Decision
2013-12-16 17:29
Return for Revision
2013-12-17 19:48
Revised
2014-01-25 08:46
Second Decision
2014-03-19 13:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2014-03-19 14:58
Articles in Press
2014-05-23 11:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-05-29 18:13
Publish the Manuscript Online
2014-06-16 16:19
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease
Manuscript Source Invited Manuscript
All Author List Nancy Khov, Amol Sharma and Thomas R Riley
Funding Agency and Grant Number
Corresponding Author Nancy Khov, MD, Department of Internal Medicine, Pennsylvania State Milton S. Hershey Medical Center and School of Medicine, 500 University Drive, Hershey, PA 17033, United States. nkhov@hmc.psu.edu
Key Words Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Liver fibrosis; Liver biopsy; Liver disease; Liver cirrhosis; Steatosis; Bedside ultrasound
Core Tip Ultrasound is a non-invasive, widely available, and accurate tool in the detection of Non-alcoholic fatty liver disease (NAFLD). Ultrasound should be used as the first-line diagnostic test in patients with abnormal liver enzymes when other causes are excluded. Clinical risk factors, when used with ultrasound findings, have high accuracy in identifying NAFLD patients. We present an algorithm for chronic abnormal liver enzymes that illustrates the use of ultrasound in reducing the need for liver biopsy in the diagnosis of NAFLD. Clinicians should be aware of the known limitations of ultrasound, including the inability to grade or stage fibrosis in NAFLD patients.
Publish Date 2014-06-16 16:19
Citation Khov N, Sharma A, Riley TR. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(22): 6821-6825
URL http://www.wjgnet.com/1007-9327/full/v20/i22/6821.htm
DOI 10.3748/wjg.v20.i22.6821
Full Article (PDF) WJG-20-6821.pdf
Full Article (Word) WJG-20-6821.doc
Manuscript File 7441-Review.docx
Answering Reviewers 7441-Answering Reviewers.pdf
Copyright License Agreement 7441-Copyright assignment.pdf
Peer-review Report 7441-Peer review(s).pdf
Scientific Editor Work List 7441-Scientific editor work list.doc